Studying the Endothelial Glycocalyx in vitro: What Is Missing?

Area of Science:

• Biomedical Engineering
• Cell Biology
• Vascular Biology

Background:

• The endothelial glycocalyx, composed of proteoglycans and glycosaminoglycans (GAGs), plays vital roles in vascular health, including barrier function and cell adhesion.
• Damage and shedding of glycocalyx components occur in numerous pathological conditions such as ischemia, sepsis, diabetes, and atherosclerosis.
• Studying glycocalyx integrity in vivo is complicated by complex inflammatory responses.

Purpose of the Study:

• To review current in vitro models used to study the endothelial glycocalyx.
• To identify the limitations of existing models in replicating in vivo conditions.
• To explore opportunities for developing improved in vitro models for glycocalyx research.

Main Methods:

• Literature review of in vitro models assessing glycocalyx structure and function.
• Analysis of models focusing on imaging, barrier function, and blood component interactions.
• Evaluation of models for their ability to incorporate multiple aspects of glycocalyx research simultaneously.

Main Results:

• Existing in vitro models have studied glycocalyx components, barrier function, or blood cell interactions separately.
• No current in vitro model simultaneously incorporates imaging, barrier function assessment, and blood component interaction.
• Limitations in current models hinder comprehensive studies of glycocalyx damage mechanisms.

Conclusions:

• There is a need for advanced in vitro models that can simultaneously assess multiple facets of glycocalyx function and damage.
• Improved models are essential for a deeper understanding of vasculopathic processes involving the glycocalyx.
• Further development of in vitro systems will enhance the study of endothelial glycocalyx in various disease states.